RJ Health Systems’ most recent April 27th Specialty Pharmacy Webinar “Utilizing NDCs for Medical Benefit Drugs – A Payor’s Perspective” focused on improving drug data capture on Medical Drug Claims. The webinar described the limitations of the HCPCS model and the value of alternatively using the FDA assigned NDC for drug billing purposes. The webinar […]
Monthly Archives: April 2016
06
Apr
Apr
The FDA have just approved a Remicade biosimilar on Tuesday, April 5th. It will go by the name “Inflectra.” Inflectra becomes the second biosimilar drug to be approved by the FDA for the U.S. market. The drug was developed by Celltrion and will be co-marketed by Pfizer. It is a form of infliximab, but will […]